Literature DB >> 23364896

Incorporation of bioactive glass in calcium phosphate cement: material characterization and in vitro degradation.

A C M Renno1, M R Nejadnik, F C J van de Watering, M C Crovace, E D Zanotto, J P M Hoefnagels, J G C Wolke, J A Jansen, J J J P van den Beucken.   

Abstract

Calcium phosphate cements (CPCs) have been widely used as an alternative to biological grafts due to their excellent osteoconductive properties. Although degradation has been improved by using poly(D,L-lactic-co-glycolic) acid (PLGA) microspheres as porogens, the biological performance of CPC/PLGA composites is insufficient to stimulate bone healing in large bone defects. In this context, the aim of this study was to investigate the effect of incorporating osteopromotive bioactive glass (BG; up to 50 wt %) on setting properties, in vitro degradation behavior and morphological characteristics of CPC/BG and CPC/PLGA/BG. The results revealed that the initial and final setting time of the composites increased with increasing amounts of incorporated BG. The degradation test showed a BG-dependent increasing effect on pH of CPC/BG and CPC/PLGA/BG pre-set scaffolds immersed in PBS compared to CPC and CPC/PLGA equivalents. Whereas no effects on mass loss were observed for CPC and CPC/BG pre-set scaffolds, CPC/PLGA/BG pre-set scaffolds showed an accelerated mass loss compared with CPC/PLGA equivalents. Morphologically, no changes were observed for CPC and CPC/BG pre-set scaffolds. In contrast, CPC/PLGA and CPC/PLGA/BG showed apparent degradation of PLGA microspheres and faster loss of integrity for CPC/PLGA/BG pre-set scaffolds compared with CPC/PLGA equivalents. Based on the present in vitro results, it can be concluded that BG can be successfully introduced into CPC and CPC/PLGA without exceeding the setting time beyond clinically acceptable values. All injectable composites containing BG had suitable handling properties and specifically CPC/PLGA/BG showed an increased rate of mass loss. Future investigations should focus on translating these findings to in vivo applications.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23364896     DOI: 10.1002/jbm.a.34531

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

2.  Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regeneration.

Authors:  Eline-Claire Grosfeld; Brandon T Smith; Marco Santoro; Irene Lodoso-Torrecilla; John A Jansen; Dietmar Jo Ulrich; Anthony J Melchiorri; David W Scott; Antonios G Mikos; Jeroen J J P van den Beucken
Journal:  Biomed Mater       Date:  2020-02-17       Impact factor: 3.715

3.  Bioglass/PLGA associated to photobiomodulation: effects on the healing process in an experimental model of calvarial bone defect.

Authors:  Angela Maria Paiva Magri; Kelly Rossetti Fernandes; Hueliton Wilian Kido; Gabriela Sodano Fernandes; Stephanie de Souza Fermino; Paulo Roberto Gabbai-Armelin; Franscisco José Correa Braga; Cíntia Pereirade Góes; José Lucas Dos Santos Prado; Renata Neves Granito; Ana Claudia Muniz Rennó
Journal:  J Mater Sci Mater Med       Date:  2019-09-07       Impact factor: 3.896

4.  Effects of sintering temperature on surface morphology/microstructure, in vitro degradability, mineralization and osteoblast response to magnesium phosphate as biomedical material.

Authors:  Zhiwei Wang; Yuhai Ma; Jie Wei; Xiao Chen; Liehu Cao; Weizong Weng; Quan Li; Han Guo; Jiacan Su
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

5.  Effect of modified compound calcium phosphate cement on the differentiation and osteogenesis of bone mesenchymal stem cells.

Authors:  Jican Zeng; Jiazhong Lin; Guanfeng Yao; Kangmei Kong; Xinjia Wang
Journal:  J Orthop Surg Res       Date:  2017-06-29       Impact factor: 2.359

Review 6.  Injectable bone cements: What benefits the combination of calcium phosphates and bioactive glasses could bring?

Authors:  Öznur Demir-Oğuz; Aldo R Boccaccini; Dagnija Loca
Journal:  Bioact Mater       Date:  2022-04-20

7.  Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions.

Authors:  Claire I A van Houdt; Paulo R Gabbai-Armelin; Paula M Lopez-Perez; Dietmar J O Ulrich; John A Jansen; Ana Claudia M Renno; Jeroen J J P van den Beucken
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.